Myomo (MYO) Debt-to-Equity : 0.07 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Myomo Debt-to-Equity?

Myomo's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.49 Mil. Myomo's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.12 Mil. Myomo's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $8.99 Mil. Myomo's debt to equity for the quarter that ended in Dec. 2023 was 0.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Myomo's Debt-to-Equity or its related term are showing as below:

MYO' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.31 Med: 0.06 Max: 1.45
Current: 0.07

During the past 8 years, the highest Debt-to-Equity Ratio of Myomo was 1.45. The lowest was -0.31. And the median was 0.06.

MYO's Debt-to-Equity is ranked better than
74.05% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs MYO: 0.07

Myomo Debt-to-Equity Historical Data

The historical data trend for Myomo's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myomo Debt-to-Equity Chart

Myomo Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.45

0.02

0.05

0.09

0.07

Myomo Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.09	0.05	0.04	0.06	0.07

Competitive Comparison of Myomo's Debt-to-Equity

For the Medical Devices subindustry, Myomo's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Myomo's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Myomo's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Myomo's Debt-to-Equity falls into.

Myomo Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Myomo's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.486	+	0.115)	/	8.989
	=	0.07

Myomo's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.486	+	0.115)	/	8.989
	=	0.07

Myomo (AMEX:MYO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Myomo Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Myomo's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Myomo (MYO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Myomo Inc (AMEX:MYO) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

0M61:Germany 0M61:Germany

Address

137 Portland Street, 4th Floor, Boston, MA, USA, 02114

Website

https://www.myomo.com

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the device to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Executives

Thomas F Kirk	director
Milton Mayo Morris	director	2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019
Paul R Gudonis	director, officer: Chief Executive Officer	9 HICKORY ROAD, MANCHESTER MA 01944
David A Henry	officer: Chief Financial Officer
Harry Kovelman	officer: Chief Medical Officer	C/O MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114
Yitzchak Jacobovitz	director	MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114
Micah Mitchell	officer: Chief Commercial Officer	C/O MYOMO, INC., ONE BROADWAY 14TH FLOOR, CAMBRIDGE MA 02139
Crowley Thomas Aloysius Jr.	director	19 ST CLAIR AV, SPRING LAKE NJ 07762
Cliff Conneighton	officer: Chief Marketing Officer	53 DEPOT ROAD, HOLLS NH 03049
Jonathan Naft	officer: VP, General Manager	C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Brandon M Green	officer: Chief Medical Officer	C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Ralph A Goldwasser	officer: Chief Financial Officer	BNN CORP, 150 CAMBRIDGEPARK DRIVE, CAMBRIDGE MA 02140
Davie Mendelsohn	officer: VP, Sales	C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Steve Sanghi	director	2355 W CHANDLER BLVD, CHANDLER AZ 85224-6199
Amy K. Knapp	director	75 N. MOUNTAIN AVE, MONTCLAIR NJ 07042